Hannover Medical School

Through SFB/Transregio 37 the position of the topics about biomedical technology as well as regenerative medicine at the 3 Hannover universities has again been significantly reinforced.
The Hannover Medical School (MHH) is concentrating its research on three areas. In addition to infection research, the SFB/Transregio 37 research activities are reflected exactly in the other two pillars of regenerative medicine/stem cell research and biomedical technology and highlight the deliberate and prominent position of these research topics at the site.

The Aachen site is known for its research efforts in the engineering sciences and natural sciences. The future structural developments are based on the successful interdisciplinary emphases such as e.g., material sciences as well as the process and production engineering. In addition, especially the "Life Sciences" with the development of biomaterials and the medical engineering as interdisciplinary emphases of the research and educational programmes are established at the RWTH Aachen. The RWTH Aachen coordinates the key research activities in six forums. The planned SFB/Transregio will continue to be represented by the Life Sciences Forum. The structure of the Life Sciences Forum includes five competency centres and research partnerships:

At the Rostock site, regenerative medicine is one of the university's key research activities in connection with biomedical technology which invigorates the Rostock University through the profile line "Life, Light and Material". Members of the SFB/Transregio 37 at the Rostock location are involved to a great extent there. With the third party projects acquired since the SFB/Transregio 37's start of funding, the acquired collaborative project "REMEDIS – Higher quality of living through new types of microimplants" (2009-2014) as part of the programme funded by BMBF "Top Level Research and Innovation in the New Federal States" is to be especially underscored. The goal of the collaborative project is the development of new types of implants for highly specific clinical applications and new possibilities for the therapy of disorders that have, up to now, not been adequately treatable.